Cortisol Measurement During Intravenous Access With a Medical Clown
Level of Cortisol in Stress Response During Intravenous Access in the Pediatric Emergency Department With a Medical Clown: a Randomized Prospective Pilot Study
1 other identifier
interventional
55
1 country
1
Brief Summary
The purpose of this study is to determine whether the presence of a medical clown in a pediatric emergency department procedure room would reduce children's anxiety. The investigators hypothesize that this positive influence will be expressed as lower levels of the stress hormone (Cortisol) in the blood.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2014
CompletedFirst Posted
Study publicly available on registry
June 20, 2014
CompletedStudy Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedJuly 26, 2018
April 1, 2016
1.7 years
June 18, 2014
July 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Cortisol level
During intravenous cannulation or blood sampling
Secondary Outcomes (1)
Vital signs (heart rate, respiratory rate, blood pressure)
During intravenous cannulation or blood sampling
Study Arms (2)
No clown
NO INTERVENTIONRoutine venipuncture without distraction
Clown
ACTIVE COMPARATORA medical clown is present in the procedure room during venipuncture
Interventions
Comparison of routine venipuncture with a distraction technique by a medical clown
Eligibility Criteria
You may qualify if:
- Patients needing venous blood sampling or insertion of an intravenous canula
- Normal development according to parents
You may not qualify if:
- Critically ill children (e.g. shock, respiratory distress or failure)
- Children whose blood work or intravenous canula must be obtained rapidly for therapeutic reasons (e.g. antibiotic administration in a patient with severe bacterial infections)
- Known adrenal or pituitary disease
- Children who have received glucocorticoids during the preceeding six weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tel Aviv Sourasky Medical Center
Tel Aviv, 64239, Israel
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayelet Rimon, MD
Tel-Aviv Sourasky Medical Center
- STUDY DIRECTOR
Miguel Glatstein, MD
Tel-Aviv Sourasky Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2014
First Posted
June 20, 2014
Study Start
August 1, 2014
Primary Completion
April 1, 2016
Study Completion
April 1, 2016
Last Updated
July 26, 2018
Record last verified: 2016-04